EP3493830
USE OF ADAMTS13 FOR TREATING, AMELIORATING AND/OR PREVENTING VASO-OCCLUSIVE CRISIS IN SICKLE CELL DISEASE, ACUTE LUNG INJURY AND/OR ACUTE RESPIRATORY DISTRESS SYNDROME
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
4.8.2017EP published:
3.12.2025EP application number:
17754240.4
EPO information:
European Patent Register
Max expiry date:
3.8.2037
Title in English:
USE OF ADAMTS13 FOR TREATING, AMELIORATING AND/OR PREVENTING VASO-OCCLUSIVE CRISIS IN SICKLE CELL DISEASE, ACUTE LUNG INJURY AND/OR ACUTE RESPIRATORY DISTRESS SYNDROMELanguage of the patent:
English
Timeline
Today
4.8.2017EP application
3.12.2025EP Publication
Owner
Name:
Takeda Pharmaceutical Company LimitedAddress:
1-1, Doshomachi 4-chome Chuo-ku, Osaka-shi, Osaka, JP
Inventor
Name:
EWENSTEIN, BruceAddress:
Brookline, MA 02445, US
Name:
GOLDSTEIN, BrahmAddress:
Thousand Oaks, California 91362, US
Name:
MAJER, BernhardAddress:
1180 Vienna, AT
Name:
ROSSATO, PaoloAddress:
1090 Vienna, AT
Name:
SCHEIFLINGER, FriedrichAddress:
1090 Vienna, AT
Name:
TURECEK, MariettaAddress:
3001 Mauerbach, AT
Priority
Number:
201662371030 PDate:
4.8.2016Country:
US
Classification
Categories:
A61K 38/48, A61P 7/02, A61P 9/00, A61P 11/00, A61P 25/04